Fevzi Demircioglu

718 total citations
5 papers, 449 citations indexed

About

Fevzi Demircioglu is a scholar working on Molecular Biology, Immunology and Allergy and Oncology. According to data from OpenAlex, Fevzi Demircioglu has authored 5 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and Allergy and 2 papers in Oncology. Recurrent topics in Fevzi Demircioglu's work include Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Connective Tissue Growth Factor Research (1 paper). Fevzi Demircioglu is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers) and Connective Tissue Growth Factor Research (1 paper). Fevzi Demircioglu collaborates with scholars based in United Kingdom, China and Portugal. Fevzi Demircioglu's co-authors include Kairbaan Hodivala‐Dilke, Ping‐Pui Wong, George Elia, Wasfi Alrawashdeh, Hemant M. Kocher, Tatjana Crnogorac‐Jurcevic, Michael R.L. Stratford, Essam Ghazaly, Cheryl L. Scudamore and Biancastella Cereser and has published in prestigious journals such as Nature, Nature Communications and Cancer Cell.

In The Last Decade

Fevzi Demircioglu

5 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fevzi Demircioglu United Kingdom	4	231	163	134	124	88	5	449
Isra Taha United States	5	195 0.8×	152 0.9×	65 0.5×	81 0.7×	56 0.6×	7	480
Erin M. Conn United States	6	399 1.7×	120 0.7×	73 0.5×	121 1.0×	96 1.1×	6	649
Sílvia Batista United Kingdom	11	278 1.2×	161 1.0×	146 1.1×	116 0.9×	93 1.1×	17	491
James Patrick Heiserman United States	7	286 1.2×	183 1.1×	55 0.4×	131 1.1×	53 0.6×	8	515
Jiangling Xiong Netherlands	6	134 0.6×	130 0.8×	93 0.7×	63 0.5×	57 0.6×	8	325
Allison P. Drain United States	5	205 0.9×	311 1.9×	106 0.8×	127 1.0×	100 1.1×	5	624
A Hill United Kingdom	7	321 1.4×	261 1.6×	106 0.8×	118 1.0×	49 0.6×	10	579
Gian Carlo Alghisi Switzerland	8	314 1.4×	125 0.8×	212 1.6×	102 0.8×	73 0.8×	9	509
Sylvie Maubant France	8	261 1.1×	103 0.6×	186 1.4×	69 0.6×	67 0.8×	20	425
Jessica Kalra Canada	11	270 1.2×	88 0.5×	75 0.6×	71 0.6×	35 0.4×	16	404

Countries citing papers authored by Fevzi Demircioglu

Since Specialization

Citations

This map shows the geographic impact of Fevzi Demircioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fevzi Demircioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fevzi Demircioglu more than expected).

Fields of papers citing papers by Fevzi Demircioglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fevzi Demircioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fevzi Demircioglu. The network helps show where Fevzi Demircioglu may publish in the future.

Co-authorship network of co-authors of Fevzi Demircioglu

This figure shows the co-authorship network connecting the top 25 collaborators of Fevzi Demircioglu. A scholar is included among the top collaborators of Fevzi Demircioglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fevzi Demircioglu. Fevzi Demircioglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lewandowska, Marta, Fevzi Demircioglu, Richard C. D. Brown, et al.. (2024). Abstract LB123: Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors. Cancer Research. 84(7_Supplement). LB123–LB123. 1 indexed citations

2.

Lechertier, Tanguy, Louise E. Reynolds, Hyojin Kim, et al.. (2020). Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth. Nature Communications. 11(1). 2810–2810. 47 indexed citations

3.

Demircioglu, Fevzi & Kairbaan Hodivala‐Dilke. (2016). αvβ3 Integrin and tumour blood vessels — learning from the past to shape the future. Current Opinion in Cell Biology. 42. 121–127. 84 indexed citations

4.

Wong, Ping‐Pui, Fevzi Demircioglu, Essam Ghazaly, et al.. (2015). Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread. Cancer Cell. 27(1). 123–137. 183 indexed citations

5.

Tavora, Bernardo, Louise E. Reynolds, Sílvia Batista, et al.. (2014). Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy. Nature. 514(7520). 112–116. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact